Latest

BioMarin Pharmaceutical expands Cork targeted therapy manufacturing facility with new lab

The Irish facility is responsible for the development and commercialisation of therapies that address genetic conditions, and this expansion will allow the company to enhance its approved medicine production capacity

Find out more

Accumulus Synergy teams up with CEPI to expedite the vaccine regulatory...

Through Accumulus' cloud-based technology, the two organisations aim to accelerate the accessibility of data for the...
See more

Neuraxpharm Group and Pharmathen partner to develop long-lasting psychiatric injectables

The co-development deal aims to enhance patient compliance, with Pharmathen and Neuraxpharm holding rights to the product in North America and Europe, respectively
You need to be a subscriber to read this article.
Click here to find out more.

Navigating challenges and charting the future of primary packaging for parenteral pharmaceuticals

Administering parenteral medications, a cornerstone of contemporary medical practice, entails injecting the drug either beneath the skin or directly into the circulatory system, reports Anna Malori, Head of Product Management at Bormioli Pharma
You need to be a subscriber to read this article.
Click here to find out more.

CDMO insights: development and manufacture of a highly potent OSD product

In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t the case

Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger

Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and accessories

Bespak and OzUK extend their joint capacity in early-stage pMDI development

The partnership will streamline the pMDI development, testing and pilot scale manufacturing processes to rapidly progress inhaled therapeutics into clinical trials

Concept and Accelero Biostructures accelerate early drug discovery with X-ray crystallography

The companies will incorporate their X-ray crystallography and drug discovery technologies to offer clients rapid hit-to-lead drug development

Stablepharma and AJ Vaccines to sign a distribution deal for SPVX02

AJ Vaccines will be responsible for the distribution and commercialisation of the fridge-free adult booster vaccine for tetanus and diphtheria across Europe

The new F-Gas Regulation and its impact on pharmaceutical freeze-drying

Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex, integrated system that balances both technical and biological specifications with economic, safety, and environmental concerns

More stories

Finance

Novavax sells protein manufacturing facility to Novo Nordisk for $200m

Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support buildings
Analysis

Medac and chiron develop organ-on chip tech for animal free drug testing

The companies aim to develop an animal-free pharmaceutical testing method that utilises organ-on chip technology, and will be used in rheumatoid arthritis drug testing
Manufacturing

Leon Nanodrugs' FR-JET nanoparticle technology proves effective in feasibility study

The company's nanoencapsulation technology worked efficiently with a broad operating window, and was deemed scalable by nanoformulation experts at Evonik Canada
Sustainability

Navin Molecular awarded gold medal by EcoVadis to recognise achievements in business sustainability

The rating places Navin Molecular in the top 5% of all companies assessed globally and improves on its bronze award achieved in 2021
Ingredients

Europa Biosite acquires life science product and service supplier, AMSBIO

Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Creating a framework to measure the impact of drug delivery devices

Alex Fong, Insights and Sustainability Lead at Owen Mumford, discusses the company’s lifecycle assessment (LCA) journey
Research & Development

First patient dosed in Phase I trial with a PARP1 selective inhibitor to treat solid tumours

Duke Street Bio is pleased to announce that the first patient has been dosed in a Phase I trial evaluating the highly selective PARP1 inhibitor, DSB2455, in patients with solid tumours
Regulatory

AstraZeneca's Imfinzi gains FDA approval for limited-stage small cell lung cancer

The immunotherapy has been approved based on the results of the Phase III ADRIATIC clinical trial, which evaluated the benefits of durvalumab in patients with limited-stage SCLC
Finance

Amgen invests $1bn into new US drug manufacturing facility

The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market
Manufacturing

Reckitt expands US OTC manufacturing footprint with North Carolina facility

The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms
Analysis

Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility

The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
Ingredients

Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription

With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence

Sponsor content

Biocair strengthens its customer focus in 2024 and prepares for another year of growth

Logistics leader launches new customer portal and expands global footprint

New Sicco desiccators and drying cabinets guide available now

Flexible and robust solutions for drying and storage

Photocatalysed flow method accelerates synthesis of potent MC4R antagonist

New automated continuous flow synthesis of spirocyclic tetrahydronaphthyridines for drug discovery

Vapourtec introduces benchtop synthesiser for peptide production

Peptide-Builder combines automation and efficiency to minimise solvent use

Thermo Fisher Scientific introduces CTS Detachable Dynabeads for cell therapy production

New products enable precise T cell isolation, advancing CAR-T therapy development

Modular automated flow synthesis of spirocyclic THNs from primary alkylamines

Asynt and the Cresswell Group achieve advances in drug discovery scaffolds

Professional high-performance fluoroplastic labware

New BOLA catalogue available now

IMA Life announces strategic partnership with RheaVita to drive further technological development and commercial growth

IMA Life makes a strategic investment in RheaVita and will support the company in advancing and commercialising its breakthrough continuous freeze-drying technology for...

IMA Ilapak Doytronic 120 wins Oscar de l’Emballage 2024 award

Innovative stand-up pouch machine recognised for primary packaging excellence

A successful polyblock system installation for solenis

Labtex have successfully designed, manufactured and installed an automated PolyBlock 2 position block heater system at Solenis

Therapeutic: felzartamab for kidney disease

Immunoglobulin A nephropathy (IgAN) or Berger disease is the most common form of primary glomerulonephritis and a leading cause of chronic kidney disease

Linkam launches CMS196V4 stage for cryo-CLEM microscopy

Linkam Scientific Instruments has announced new updates to its specialist CMS196 cryo-stage. The CMS196V4 supports cryo-correlative light and electron microscopy...

Featured companies

Bormioli Pharma partners with the pharmaceutical industry and all companies that are working towards the future of healthcare globally. As a world-renowned player in the... Contract development and manufacturing of Potent and non Potent APIs PCI Pharma Services: Your bridge between life-changing therapies and patients. Gerresheimer is the global partner for pharmaceutics, biotech, healthcare, and cosmetics with a very broad product range for pharmaceutical and cosmetic containment solutions...
See more

Resource Centre

Latest Media See all

Manufacturing Chemist Stand Side with Enzene Biosciences at CPHI Milan 2024

Manufacturing Chemist Stand Side with Enzene Biosciences at CPHI Milan 2024

Manufacturing Chemist Stand Side with ICROM srl

Manufacturing Chemist Stand Side with ICROM srl

Manufacturing Chemist Stand Side with Quotient Sciences

Manufacturing Chemist Stand Side with Quotient Sciences

Manufacturing Chemist Stand Side with Almac Group

Manufacturing Chemist Stand Side with Almac Group

Latest Reports See all

Why potency assays are a crucial consideration for CGT manufacturers

Potency assays can enhance the efficiency of cell and gene therapy development and commercialisation while also bringing down costs

How iPSCs can bridge the translational gap in neuroscience

Affecting more than one in three people, neurological disorders have a vast impact on global health while exacting a tremendous cost, reports Dr Max Mirza, Vice President of...

Clinical trials: current insights and future perspectives

To keep up with the ever-evolving landscape of clinical trials, companies must conform to regulations and consider how to make the study process patient-centric

Recombinant versus synthetic peptide synthesis: the perks and drawbacks

Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin

Company News

AstraZeneca appoints Iskra Reic as its International Executive Vice President Iskra will be responsible for championing AstraZeneca's growth across key markets globally, as well as business strategy development
Ann-Xiaoyan Li appointed new Group CFO and Managing Director of the Romaco Group New member on the Romaco Group Board of Management
Merck appoints Surendralal L. Karsanbhai to its board of directors The President and CEO of Emerson Electric will work with the 13-strong board to oversee the management of Merck's global business endeavours
Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
Biosynth appoints Matt Gunnison as its new CEO and Kieran Murphy as Chair Matt and will both assume their places on the Board of Directors, and will work to strengthen the company's position in the life sciences sector
Wheeler Bio appoints Patrick Lucy as chief executive officer Experienced leader to guide the company towards integrated commercial-scale operations
Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board The two will work to advance the company's global presence, while developing its lead programme
Mosaic Therapeutics appoints Dr Barry Davies as its CSO Barry will bring more than 25 years of experience in drug development and lead optimisation to the table
See more

Upcoming events See all

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual

Pharmapack

22 – 23 January 2025 | Exhibition | Paris, France

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US

About Manufacturing Chemist

Through digital, live and print products, Manufacturing Chemist informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry from ingredients and packaging to regulation, retail and marketing.

Pharma 5.0 represents a paradigm shift in pharmaceutical manufacturing, paving the way for a future where medications are developed faster, customised to individual patient needs and delivered with uncompromising quality. It is not just about innovation; it is about transforming the way we think about healthcare and ultimately improving the lives of patients around the world.